Total Payments
$2,646
2024 Payments
$438.22
Companies
11
Transactions
49
Medicare Patients
1,143
Medicare Billing
$205,357
Payment Breakdown by Category
Food & Beverage$2,646 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,646 | 49 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $612.32 | 6 | $0 (2023) |
| Alexion Pharmaceuticals, Inc. | $435.14 | 5 | $0 (2024) |
| PFIZER INC. | $377.80 | 18 | $0 (2024) |
| Genentech USA, Inc. | $375.00 | 3 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $241.82 | 9 | $0 (2024) |
| Gilead Sciences, Inc. | $235.00 | 2 | $0 (2019) |
| Neurocrine Biosciences, Inc. | $163.43 | 1 | $0 (2023) |
| Eisai Inc. | $125.00 | 1 | $0 (2023) |
| Allergan Inc. | $40.28 | 2 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $24.55 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $438.22 | 16 | PFIZER INC. ($243.64) |
| 2023 | $824.72 | 12 | Alexion Pharmaceuticals, Inc. ($275.68) |
| 2022 | $312.66 | 4 | ABBVIE INC. ($240.64) |
| 2021 | $263.34 | 4 | AbbVie Inc. ($246.56) |
| 2019 | $125.00 | 1 | Gilead Sciences, Inc. ($125.00) |
| 2018 | $509.24 | 9 | Genentech USA, Inc. ($375.00) |
| 2017 | $172.80 | 3 | Gilead Sciences Inc ($110.00) |
All Payment Transactions
49 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $23.55 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/01/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/01/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/23/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/21/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/12/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/12/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/14/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/30/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/05/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/19/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $122.91 | General |
| Category: Rare Disease | ||||||
| 03/19/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/06/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/09/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/23/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $26.46 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/12/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/13/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $28.88 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/01/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/30/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $24.44 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/13/2023 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Neurology | ||||||
| 10/06/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/08/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/08/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $124.96 | General |
| Category: Rare Disease | ||||||
| 04/26/2023 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $125.12 | General |
| Category: NEUROSCIENCE | ||||||
| 03/30/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $163.43 | General |
| Category: Neuropsychiatry | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 230 | 504 | $150,004 | $38,647 |
| 2022 | 6 | 305 | 665 | $205,656 | $49,584 |
| 2021 | 4 | 290 | 746 | $223,384 | $54,952 |
| 2020 | 5 | 318 | 834 | $243,769 | $62,173 |
Total Patients
1,143
Total Services
2,749
Medicare Billing
$205,357
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 130 | 403 | $111,228 | $29,354 | 26.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 79 | 80 | $22,480 | $6,054 | 26.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 21 | 21 | $16,296 | $3,239 | 19.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 157 | 501 | $138,276 | $33,537 | 24.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 29 | 31 | $24,056 | $5,529 | 23.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 71 | 77 | $21,637 | $5,253 | 24.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 15 | 22 | $8,734 | $2,096 | 24.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 13 | 14 | $7,373 | $1,830 | 24.8% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 20 | 20 | $5,580 | $1,339 | 24.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 151 | 562 | $155,112 | $38,242 | 24.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 41 | 82 | $32,554 | $8,034 | 24.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 70 | 74 | $20,794 | $5,083 | 24.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 28 | 28 | $14,924 | $3,592 | 24.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 164 | 625 | $166,177 | $42,466 | 25.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 24 | 73 | $27,791 | $7,183 | 25.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 48 | 53 | $27,391 | $6,826 | 24.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 68 | 69 | $18,647 | $4,733 | 25.4% |
| 99217 | Hospital observation care on day of discharge | Facility | 2020 | 14 | 14 | $3,763 | $965.92 | 25.7% |
About Dr. Gary Guo, MD
Dr. Gary Guo, MD is a Internal Medicine healthcare provider based in Valhalla, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1932129582.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gary Guo, MD has received a total of $2,646 in payments from pharmaceutical and medical device companies, with $438.22 received in 2024. These payments were reported across 49 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($2,646).
As a Medicare-enrolled provider, Guo has provided services to 1,143 Medicare beneficiaries, totaling 2,749 services with total Medicare billing of $205,357. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Valhalla, NY
- Active Since 07/19/2006
- Last Updated 02/29/2008
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1932129582
Products in Payments
- UBRELVY (Drug) $487.20
- ULTOMIRIS (Biological) $398.59
- ELIQUIS (Drug) $361.02
- TECENTRIQ (Biological) $250.00
- Vemlidy (Drug) $235.00
- XARELTO (Drug) $226.46
- INGREZZA (Drug) $163.43
- QULIPTA (Drug) $125.12
- Alecensa (Biological) $125.00
- Leqembi (Drug) $125.00
- SOLIRIS (Drug) $36.55
- TEFLARO (Drug) $26.25
- ENTRESTO (Drug) $24.55
- VYNDAQEL (Drug) $16.78
- Reveal LINQ (Device) $15.64
- INVOKANA (Drug) $15.36
- AVYCAZ (Drug) $14.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Valhalla
Dr. Jay Doshi, M.d, M.D
Internal Medicine — Payments: $96,684
Internal Medicine $96,684
Luciano De Marco, M.d, M.D
Internal Medicine — Payments: $14,149
Internal Medicine $14,149
Neal Shah, M.d, M.D
Internal Medicine — Payments: $5,403
Internal Medicine $5,403
Sade Solola Nussbaum, Md, MD
Internal Medicine — Payments: $4,024
Internal Medicine $4,024
Rhonda Rubin, Md, MD
Internal Medicine — Payments: $2,982
Internal Medicine $2,982
Adrese Kandahari, M.d, M.D
Internal Medicine — Payments: $2,880
Internal Medicine $2,880